moderna
for pharma researchers, biotech founders
Why this scored 25
every term, weightedIts fastest-moving item, measured against the pace of its own source
Whether that velocity is itself speeding up, as a per-hour rate
How many independent communities its own items come from
Decays to zero over 14 days, counted from when we first saw it
Subtracted once something is big and old — sized by its biggest item, aged from when we first saw it
Weights are hand-tuned, not learned — we're calibrating them against realized trends as history accumulates. On an entity's first sighting there's no previous reading to compare against, so acceleration starts from a neutral prior rather than a measurement, and velocity falls back to engagement over its whole lifetime until a second reading exists. Full methodology
Signal history
7-day window (free)The evidence
The live items this entity's score aggregates — every community independently talking about it right now. This is the corroboration, shown, not claimed.
- 147
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
mRNA vaccine shows 42% reduction in death and recurrence rates. · for pharma researchers, biotech founders
hackernewsCoolingscience57m ago - 216
Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma
Phase 3 shows Moderna's mRNA neoantigen vaccine effective against melanoma. · for biotech founders, pharma R&D
hackernewsSteadyscience67d ago